These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 21160385)

  • 1. Amelioration of hypoglycemia with octreotide therapy in metastatic insulinoma with positive octreotide scan.
    Wade AN; Cheng G; Teitelbaum U; Patel AA; Alavi A; Rickels MR
    Pancreas; 2011 Jan; 40(1):173-5. PubMed ID: 21160385
    [No Abstract]   [Full Text] [Related]  

  • 2. Remission of symptoms of chemotherapy-refractory metastatic insulinoma using octreotide.
    Longnecker SM
    Drug Intell Clin Pharm; 1988 Feb; 22(2):136-8. PubMed ID: 2894965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
    Glaser B; Rösler A; Halperin Y
    Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe hypoglycaemia after long-acting octreotide in a patient with an unrecognized malignant insulinoma.
    Healy ML; Dawson SJ; Murray RM; Zalcberg J; Jefford M
    Intern Med J; 2007 Jun; 37(6):406-9. PubMed ID: 17535385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapy of endocrine gastrointestinal-pancreatic tumors with somatostatin analog octreotide].
    Arnold R; Neuhaus C; Trautmann ME
    Dtsch Med Wochenschr; 1992 Jul; 117(27):1067-71. PubMed ID: 1352235
    [No Abstract]   [Full Text] [Related]  

  • 6. No effect of the long-acting somatostatin analogue octreotide in patients with insulinoma.
    Timmer R; Koningsberger JC; Erkelens DW; Thijssen JH; Lips CJ; Koppeschaar HP
    Neth J Med; 1991 Jun; 38(5-6):199-203. PubMed ID: 1922592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of insulinoma by a single daily dose of octreotide in two elderly female patients.
    Kishikawa H; Okada Y; Hirose A; Tanikawa T; Kanda K; Tanaka Y
    Endocr J; 2006 Feb; 53(1):79-85. PubMed ID: 16543676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulinoma and octreotide].
    Stehouwer C
    Ned Tijdschr Geneeskd; 1992 Jun; 136(25):1221. PubMed ID: 1614574
    [No Abstract]   [Full Text] [Related]  

  • 9. Glucose-responsive and octreotide-sensitive insulinoma.
    Izumiyama H; Gotyo N; Fukai N; Ozawa N; Doi M; Yoshimoto T; Arii S; Hirata Y
    Intern Med; 2006; 45(8):519-24. PubMed ID: 16702744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [46-year-old man with hypoglycemia after seizure. Insulinoma].
    Vardarli I; Fenske A; Nauck MA; Jäckel E; Leitolf H
    Dtsch Med Wochenschr; 2010 May; 135(18):913-4. PubMed ID: 20425676
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolic remission with octreotide in patients with insulinoma.
    von Eyben FE; Grodum E; Gjessing HJ; Hagen C; Nielsen H
    J Intern Med; 1994 Mar; 235(3):245-8. PubMed ID: 8120520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Benign insulinoma. Efficacy of preoperative treatment for persistent hyperinsulinemia using a synthetic somatostatin analog].
    Esposito V; Esposito D; Lo Iudice G; Rispoli C; Verrillo A; D'Alessandro B
    Minerva Endocrinol; 1994 Mar; 19(1):33-7. PubMed ID: 8035768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment of benign insulinoma using octreotide LAR: a case report.
    Usukura M; Yoneda T; Oda N; Yamamoto Y; Takata H; Hasatani K; Takeda Y
    Endocr J; 2007 Feb; 54(1):95-101. PubMed ID: 17124362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin).
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH; Naafs MA
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):34-40. PubMed ID: 2545062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin analogues in the management of benign insulinomas.
    Laron Z
    Isr J Med Sci; 1990 Jan; 26(1):1-2. PubMed ID: 2155883
    [No Abstract]   [Full Text] [Related]  

  • 16. The role of somatostatin analogs in the treatment of endocrine gastrointestinal tumors.
    Trautmann ME; Neuhaus C; Lenze H; Benning R; Benning M; Dennler HJ; Bruns C; Joseph K; Arnold R
    Horm Metab Res Suppl; 1993; 27():24-7. PubMed ID: 8392487
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the long-acting somatostatin analogue octreotide in the management of insulinoma in three dogs.
    Simpson KW; Stepien RL; Elwood CM; Boswood A; Vaillant CR
    J Small Anim Pract; 1995 Apr; 36(4):161-5. PubMed ID: 7603057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant insulinoma: lack of response to the somatostatin analog SMS 201-955].
    Ligorria C; Montaña E; Virgili N
    Med Clin (Barc); 1989 Nov; 93(17):676. PubMed ID: 2559266
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma.
    Shojamanesh H; Gibril F; Louie A; Ojeaburu JV; Bashir S; Abou-Saif A; Jensen RT
    Cancer; 2002 Jan; 94(2):331-43. PubMed ID: 11900219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful long-term treatment with once-daily injection of low-dose octreotide in an aged patient with insulinoma.
    Katabami T; Kato H; Shirai N; Naito S; Saito N
    Endocr J; 2005 Oct; 52(5):629-34. PubMed ID: 16284444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.